Acorah Software Products - Accounts Production 19.2.450 true true 31 July 2024 1 August 2023 false true No description of principal activity 1 August 2024 31 July 2025 31 July 2025 12759844 Mr G A Edmondson iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12759844 2024-07-31 12759844 2025-07-31 12759844 2024-08-01 2025-07-31 12759844 frs-bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 12759844 frs-bus:FilletedAccounts 2024-08-01 2025-07-31 12759844 frs-bus:Micro-entities 2024-08-01 2025-07-31 12759844 frs-bus:EntityHasNeverTraded 2024-08-01 2025-07-31 12759844 frs-bus:AuditExempt-NoAccountantsReport 2024-08-01 2025-07-31 12759844 frs-bus:Director1 2024-08-01 2025-07-31 12759844 2023-07-31 12759844 2024-07-31 12759844 2023-08-01 2024-07-31
Registered number: 12759844
Pressco Medical Limited
Unaudited Financial Statements
For The Year Ended 31 July 2025
Phelan Cloud Accounting
Chartered Certified Accountants
18 New Road
Clanfield
Waterlooville
Hampshire
PO8 0NS
Balance Sheet
Registered number: 12759844
2025 2024
£ £
Current assets 1 1
NET CURRENT ASSETS 1 1
TOTAL ASSETS LESS CURRENT LIABILITIES 1 1
NET ASSETS 1 1
CAPITAL AND RESERVES 1 1

Notes

1. General Information
Pressco Medical Limited is a private company, limited by shares, incorporated in England & Wales, registered number 12759844 . The registered office is C/O Phelan Cloud Accounting, 18 New Road, Clanfield, Hampshire, PO8 0NS.
2. Average Number of Employees
Average number of employees, including directors, during the year was as follows: 1 (2024: 1)
1 1
For the year ending 31 July 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr G A Edmondson
Director
7 July 2026